Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles
 

Open Access

Original Research

RMJ. 2010; 35(1): 54-56


Frequency of silent ischemic heart disease in type 2diabetic patients

Inamullah Khan, Zahidullah Khan, Hamza Khan, Fazle Subhan, Jamal Ud Din, Bughdad Khan, Sadiq ur Rehman..

Abstract
Objectives
To determine the frequency of silent myocardial ischemia
(SMI) in type 2 diabetic patients.
Patients and Methods
This study was conducted in Medical units of Khyber Teaching Hospital,
Peshawar from February 2009 to August 2009. A total of 100 patients who
had type 2 diabetes mellitus (DM) for 5 years or more, were included in the
study. All patients with type 1 DM, symptomatic ischemic heart disease,
previous myocardial or valvular heart disease were excluded from the
study. Full blood count and fasting blood glucose were performed in all
patients. The main tools for the diagnosis were electrocardiogram, exercise
tolerance test (ETT) and echocardiography. Patients having normal
electrocardiogram and exercise tolerance test were labeled as having no
silent ischemic heart disease. Those patients who turned out to have silent
ischemic heart disease were subjected to echocardiography.
2
Results
Out of 100 patients, 50 were male and 50 female. Forty-four
out of 100 (44%) had silent myocardial ischemia. Among these
44 patients, 25 were male and 19 female (1.3:1). The majority
of patients were in the age group of 50-59.
Conclusion
All patients with type 2 diabetes of more than 5 years duration
should be screened with ETT for silent myocardial ischemia.
(Rawal Med J 2010;35: ).

Key words: Silent ischemic heart disease, type 2 diabetes mellitus, silent myocardial ischemia.



Similar Articles

Exploring the Alzheimer's disease neuroepigenome: recent advances and future trends.
Zhang H, Elefant F
Neural regeneration research. 2022; 17(2): 325-327

Growth differentiation factor 5: a neurotrophic factor with neuroprotective potential in Parkinson's disease.
Goulding SR, Anantha J, Collins LM, Sullivan AM, O'Keeffe GW
Neural regeneration research. 2022; 17(1): 38-44

Differentiating Human Pluripotent Stem Cells to Vascular Endothelial Cells for Regenerative Medicine, Tissue Engineering, and Disease Modeling.
Bertucci T, Kakarla S, Kim D, Dai G
Methods in molecular biology (Clifton, N.J.). 2022; 2375(): 1-12

Presenilin mutations and their impact on neuronal differentiation in Alzheimer's disease.
Hernandez-Sapiens MA, Reza-Zaldívar EE, Márquez-Aguirre AL, Gómez-Pinedo U, Matias-Guiu J, Cevallos RR, Mateos-Díaz JC, Sánchez-González VJ, Canales-Aguirre AA
Neural regeneration research. 2022; 17(1): 31-37

Gas phase ion-molecule reactions of nitroaromatic explosive compounds studied by hollow cathode discharge ionization-mass spectrometry.
Hong H, Habib A, Bi L, Wen L
Talanta. 2022; 236(): 122834


Full-text options


Latest Statistics about COVID-19
• pubstat.org


Add your Article(s) to Indexes
• citeindex.org






Covid-19 Trends and Statistics
ScopeMed.com
CiteIndex.org
CancerLine
FoodsLine
PhytoMedline
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.



ScopeMed Web Sites